Synthetic Biologics, Inc. carries a market capitalization of 16.16M, placing it among publicly traded companies globally.
| Market Cap | 16.16M |
| Enterprise Value | N/A |
Synthetic Biologics, Inc.'s stock has declined approximately -58.36735% over the past 52 weeks. The 50-day moving average sits at 1.24, while the 200-day moving average is 2.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -58.36735% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 2.05 |
| Average Volume (20 Days) | N/A |
Synthetic Biologics, Inc.'s most recent stock split took place on July 25, 2022 with a 10:1 split ratio.
| Last Split Date | 7/25/2022 |
| Split Ratio | 10:1 |